Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
S. Khanolkar (Airoli, India), R. Thale (Airoli, India), M. Bolshete (Airoli, India), V. Jakhetia (Airoli, India), P. Bolshete (Airoli, India). Publication rate and characteristics of industry-sponsored asthma clinical trials. 4815

Member's Comments

No comment yet.

Related content which might interest you: Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Current clinical trials Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019 Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Safety of formoterol in asthma clinical trials: an update Source: Eur Respir J 2014; 43: 103-114 Year: 2004 Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs) Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection. Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Patient perspective of participation in COVID-19 clinical trials Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases Year: 2021 Clinical trials and outcome measures Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe Year: 2013 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 Clinical trials design in the age of precision medicine Source: ERS webinar 2020: Clinical trials design in the age of precision medicine Year: 2020 Clinical effectiveness of MDI-HFA-Modulite beclomethasone in the treatment of asthma – meta-analysis of randomized controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Preschool asthma - have randomised controlled trials provided clarity on management? Source: International Congress 2018 – Infectious agents and childhood asthma Year: 2018 Safety of formoterol in asthma clinical trials Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD Source: International Congress 2017 – Management of COPD Year: 2017 Seasonal pattern of exacerbation rates in the tiotropium clinical trial database Source: Eur Respir J 2007; 30: Suppl. 51, 609s Year: 2007 Run-in bias in randomised trials: the case of COPD medications Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017 Year: 2017 A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019 A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 Year: 2019